drugset / Trial / NCT01870206

Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns

NCT01870206 ↗

Phase 3 Unknown 320 enrolled Birmex
RandomizedParallel-groupTriple-blind

Summary

Polio is a highly infectious disease caused by a virus. It invades the nervous system, and can cause total paralysis in a matter of hours. The virus enters the body through the mouth and multiplies in the intestine. Initial symptoms are fever, fatigue, headache, vomiting, stiffness in the neck and pain in the limbs. One in 200 infections leads to irreversible paralysis (usually in the legs). Among those paralysed, 5% to 10% die when their breathing muscles become immobilized. There is no cure for polio, it can only be prevented. Polio vaccine, given multiple times, can protect a child for life. Compare in newborns the immunogenicity and safety of the vaccine OPV produced by Birmex compared with the vaccine OPV produced by Sanofi Pasteur, both produced in Vero cells.

Timeline

Start
2013-06
Primary completion
2013-12
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Trivalent OPV Birmex Vaccine — —
Comparator Trivalent OPV Sanofi Pasteur Vaccine — —

Indications